Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Clinical trial NCT03180502 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03180502
Sponsor: NRG Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Diffuse Astrocytoma Glioma Oligoastrocytoma Oligodendroglioma WHO Grade 3 Glioma

Start date: 2018-01-23
Primary completion: 2026-07-13
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.